Robert N. Eisenman

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Basic Sciences
Member
University of Washington
School of Medicine
Biochemistry
Affiliate Professor
Professional Headshot of Robert N. Eisenman

Mailing Address

Fred Hutchinson Cancer Research Center
MS A2-015
P.O. Box 19024
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-4445
Fax: (206) 667-6522
eisenman@fhcrc.org

Qualifications

Postdoctoral, Massachusetts Institute of Technology, Cell Biology, 1976.
Postdoctoral, Institut Suisse de Recherche Experimentale sur le Cancer, Virology, 1975.
Ph.D., University of Chicago, Biophysics, 1971.

Expertise and Research Interests

Transcriptional Regulation of Cellular Functions
The broad goal of research in my laboratory is to understand how cell proliferation, growth, and differentiation are regulated through the actions of specific transcription factors. Over the last decade we have focused on a transcription factor network - the Max network- whose interacting components together comprise a transcriptional switching system that has been highly conserved throughout evolution. One of the components of the network is the Myc oncoprotein, the product of an oncogene profoundly involved in the genesis of many different tumors, but also normally involved in cell proliferation, differentiation, and death. Myc interacts in a specific manner with its dimerization partner, Max, permitting the Myc-Max heterodimer to bind DNA and regulate gene expression. Max also interacts with other proteins, including a group called the Mad family. Mad:Max heterodimers repress transcription at Myc:Max binding sites and thus appear to oppose the gene activation function of Myc:Max. Thus the Max network comprises positive and negative regulators of gene expression. We are using genetic and molecular analyses in mammalian systems and in Drosophila to understand the biological roles of this transcription factor network.

Mechanisms of transcriptional regulation
How does the Max network repress and activate gene expression? Recent evidence suggests that these transcription factors influence gene expression by modification of chromatin structure of specific target genes. The laboratory has shown that Mad-Max dimers can silence gene expression by recruiting a large co-repressor complex (the mSin3 complex) which in turn is associated with a histone deacetylase (HDAC) activity. HDAC removes acetyl groups from the N-terminal tails of nucleosomal histones leading to an inaccessible or repressed chromatin conformation. Work from other laboratories has shown that Myc interacts with the TRRAP co-activator complex to recruit histone acetyl transferases (HATs) and chromatin remodeling factors. Recently we have used a genetic screen in Drosophila to identify Lid (Jarid 1A), a Jumonji domain containing protein, as an important component of Myc's ability to stimulate growth in the fly eye. Moreover we have demonstrated that Lid is a histone demethylase specific for trimethylated lysine 4 in histone H3 (H3-K4me3). Interestingly interaction with Myc inhibits Lid demethylase activity perhaps serving to maintain the active trimethylated state of H3-K4. We are also studying the interaction of mammalian Myc with Rbp2, the ortholog of Lid.


Biological roles of the Max Network
A major project is to understand the primary biological functions of Myc and other network proteins. Our discovery of homologs of Myc, Max and Mad in Drosophila has also permitted us to initiate a genetic analysis of the network in order to delineate its gene targets, the factors which regulate its expression patterns, and other interacting pathways. The Drosophila studies (in collaboration with the Edgar and Parkhurst labs, FHCRC) indicate that Myc and Mad act to determine the size of cells by influencing cell growth. These findings also apply to mammalian cells where we have found that Myc overexpression leads to an increase in cell mass and protein synthesis while Mad expression generates smaller cells. Global expression studies indicate that Myc and Mad have opposing transcriptional effects on overlapping gene targets. To understand how the Max network proteins regulate cell growth we carried out a project aimed at identifying direct binding sites for Drosophila Myc, Max and Mad. This work indicates that Max network proteins bind widely to genomic DNA and probably regulate the expression of hundreds of target genes.

In order to understand how Myc functions during normal development we have produced a nervous system-specific deletion of the N-myc gene in mice and demonstrated that N-myc is required for neural progenitor cell expansion and the inhibition of neuronal differentiation early during nervous system development. Loss of N-myc leads to growth arrest of progenitor cells due, at least in part, to premature differentiation and to an inability to turn off cyclin dependent kinase inhibitors. This study has also shown that loss of Myc function in cells results in global changes in chromatin structure apparently leading to a loss in accessibility of DNA within chromatin. Together with the binding studies in mammalian and Drosophila cells our data suggest that Myc-Max may function to regulate the accessibility of large regions of DNA. Because the Myc cofactor Lid/Rbp2 belongs to the larger group of Trithorax proteins we are investigating the role of Myc and Rbp2 in altering the dynamics of Trithorax-Polycomb interactions in murine embryonic stem cells during differentiation.

Other Expertise

Scientific Advisory Committee, Center for Integrative Genomics, Lausanne Switzerland, 2007-
Scientific Advisory Board Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland 1998-2006
Scientific Advisory Board, Lineberger Cancer Center, University of North Carolina 1999-2005
Board Of Scientific Counselors, Division of Basic Sciences, National Cancer Institute, NIH. 1996-2000
Jane Coffin Childs Memorial Fund for Medical Research, Board of Scientific Advisors 1999-2007
Pew Scholars Program in the Biomedical Sciences, National Advisory Committee 2003-2009
Advisory Board, Foundation for Advanced Cancer Research
Editorial Boards: Molecular & Cellular Biology; Journal of Cell Biology

Industrial Relevance

Scientific Advisory Board, Agensys Inc. Santa Monica
Scientific Advisory Board, Otogene Inc., Seattle

Keywords

COS Keywords:

Biochemistry, Biochemistry, Proteins, Biophysics, Cancer or Carcinogenesis, Cell Biology, Cell Differentiation, Cell Proliferation, Gene Expression, Transcription, Virology.

Additional Terms:

Cancer, Development.

Memberships

American Academy of Arts and Sciences
American Academy of Microbiology
American Association for Cancer Research
American Association for the Advancement of Science
American Society for Microbiology
National Academy of Sciences

Honors and Awards

2007, Co-organizer, conference on the Myc/Max/Mad Transcription Factor Network, CNIO Madrid
2005, The Sternlicht Lecture, Case-Western Reserve University
2005, Merck-Frosst Lecture, ICRM, Montreal
2005, Elkan Distinguished Lecturer, Winship Cancer Center, Emory University
2004Chiron Lectures, University of California, Berkeley
2004, Doctorate (honoris causa), University of Lausanne
2003Elected, American Academy of Arts and Sciences
2003, MERIT AWARD, National Institutes of Health (NIH)
2002, Landon-AACR Prize, Landon Foundation-American Association for Cancer Research, Basic Cancer Research
2001, The Harvey Lecture, The Harvey Society, Rockefeller University
1998, Elected, National Academy of Sciences,
1997, American Cancer Society Research Professor, American Cancer Society
1990, MERIT Award NIH, NIH
1979-1984, Scholar, Leukemia Society of America
1974-1975, Special Postdoctoral Fellowship, Leukemia Society of America
1973-1974, Long-term Postdoctoral Fellowship, European Molecular Biology Organization
1971-1973, Postdoctoral Fellow, Damon Runyon Cancer Foundation
1965, C.H. Willey Prize in Biology, New York University

Previous Positions

1975-1976, Postdoctoral Fellow, Massachusetts Institute of Technology, Cancer Center
1971-1975, Postdoctoral Fellow, Swiss Institute for Experimental Cancer Research

Patents

Nucleic acids encoding regulatory proteins that dimerize with Max, Patent Number: 5624818, 1997.
Nucleic acids encoding max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc and Mad, Patent Number: 5693487, 1997, United States of America.
Method of producing a Mad polypeptide, Patent Number: 5 302 519, 1994, , United States of America.

Publications

  • Secombe, J. et al. (2007) The Trithorax group protein Lid is a trimethyl histone H3-K4 demethylase required for dMyc-induced cell growth., Genes & Development, 21, 537
  • Knoepfler, P. S. et al (2006) Myc influences global chromatin structure, EMBO Journal, 25, 2723
  • Hatton, BA; et al. (2006) N-myc Is an Essential Downstream Effector of Shh Signaling during both Normal and Neoplastic Cerebellar Growth, Cancer Research, 66, 8655
  • Zindy, F. et al. (2006) N-Myc and the cyclin-dependent kinase inhibitors, p18Ink4c and p27Kip1, coordinately regulate cerebellar development, PNAS, 103, 11579
  • Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ, C-Myc Binds to Human Ribosomal DNA and Stimulates Transcription of RRNA Genes By RNA Polymerase I., Nature Cell Biology, 7(3), 311-8, Mar 2005 Abstract
  • Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA, Myc-dependent Regulation of Ribosomal RNA Synthesis During Drosophila Development., Nature Cell Biology, 7(3), 295-302, Mar 2005 Abstract
  • Okubo T, Knoepfler PS, Eisenman RN, Hogan BL, Nmyc Plays An Essential Role During Lung Development As a Dosage-sensitive Regulator of Progenitor Cell Proliferation and Differentiation., Development (cambridge, England), 132(6), 1363-74, Mar 2005 Abstract
  • Welcker M, Orian A, Grim JA, Eisenman RN, Clurman BE, A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates C-Myc and Cell Size., Current Biology : Cb, 14(20), 1852-7, Oct 2004
  • Swanson KA, Knoepfler PS, Huang K, Kang RS, Cowley SM, Laherty CD, Eisenman RN, Radhakrishnan I, HBP1 and Mad1 Repressors Bind the Sin3 Corepressor PAH2 Domain With Opposite Helical Orientations., Nat Struct Mol Biol, 11(8), 738-46, Aug 2004
  • Welcker M, Orian A, Jin J, Grim JA, Harper JW, Eisenman RN, Clurman BE, The Fbw7 Tumor Suppressor Regulates Glycogen Synthase Kinase 3 Phosphorylation-dependent C-Myc Protein Degradation., Proceedings of the National Academy of Sciences of the United States of America., 101(24), 9085-90, Jun 2004
  • Pierce SB, Yost C, Britton JS, Loo LW, Flynn EM, Edgar BA, Eisenman RN, DMyc Is Required for Larval Growth and Endoreplication in Drosophila., Development (cambridge, England), 131(10), 2317-27, May 2004
  • Cowley SM, Kang RS, Frangioni JV, Yada JJ, DeGrand AM, Radhakrishnan I, Eisenman RN, Functional Analysis of the Mad1-mSin3A Repressor-corepressor Interaction Reveals Determinants of Specificity, Affinity, and Transcriptional Response., Molecular and Cellular Biology, 24(7), 2698-709, Apr 2004
  • Secombe J, Pierce SB, Eisenman RN, Myc: a Weapon of Mass Destruction., Cell, 117(2), 153-6, Apr 2004
  • Gomez-Roman N, Grandori C, Eisenman RN, White RJ, Direct activation of RNA polymerase III transcription by c-Myc, Nature, 421(6920), 290-4, January 2003 Abstract
  • Shiio Y, Donohoe S, Yi EC, Goodlett DR, Aebersold R, Eisenman RN, Quantitative proteomic analysis of Myc oncoprotein function, The Embo Journal, 21(19), 5088-96, October 2002 Abstract
  • Iritani BM, Delrow J, Grandori C, Gomez I, Klacking M, Carlos LS, Eisenman RN, Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1, The Embo Journal, 21(18), 4820-30, September 2002 Abstract
  • McArthur GA, Foley KP, Fero ML, Walkley CR, Deans AJ, Roberts JM, Eisenman RN, MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity, Molecular and Cellular Biology, 22(9), 3014-23, May 2002 Abstract
  • Eisenman RN, Deconstructing myc, Genes and Development, 15(16), 2023-30, August 2001 Abstract
  • Brubaker K, Cowley SM, Huang K, Loo L, Yochum GS, Ayer DE, Eisenman RN, Radhakrishnan I, Solution structure of the interacting domains of the Mad-Sin3 complex: Implications for recruitment of a chromatin-modifying complex, Cell, 103(4), 655-65, 2000
  • Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, Eisenman RN, Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif, Embo Journal, 18(24), 7019-28, December 1999 Abstract
  • Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P, Drosophila myc regulates cellular growth during development, Cell, 98(6), 779-90, September 1999 Abstract
  • Laherty CD, Billin AN, Lavinsky RM, Yochum GS, Bush AC, Sun JM, Mullen TM, Davie JR, Rose DW, Glass CK, Rosenfeld MG, Ayer DE, Eisenman RN, SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors, Molecular Cell, 2(1), 33-42, July 1998 Abstract
  • Foley KP, McArthur GA, Queva C, Hurlin PJ, Soriano P, Eisenman RN, Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation, Embo Journal, 17(3), 774-85, February 1998 Abstract
  • Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN, Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression, Cell, 89(3), 349-56, May 1997 Abstract

Profile Details

Last Verified: 10/15/2007

COS Expertise ID #441228
Reference this profile directly: http://myprofile.cos.com/reisenman